0.3929

13.00% 0.0452

After Hours: .41 0.0171 +4.35%

Fibrobiologics Inc (FBLG)

Overview News Price History Discussions Forecast

Fibrobiologics Inc stock is traded at $0.3929, with a volume of 1.84M. It is up +13.00% in the last 24 hours and up +19.75% over the past month. FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.

Previous Close:

$0.3477

Open:

$0.38

24h Volume:

1.84M

Relative Volume:

1.56

Market Cap:

$24.08M

Revenue:

Net Income/Loss:

$-17.78M

P/E Ratio:

-0.7154

EPS:

-0.5492

Net Cash Flow:

$-10.52M

1W Performance:

+49.00%

1M Performance:

+19.75%

6M Performance:

-54.97%

1Y Performance:

-82.69%

1-Day Range:

$0.36

$0.409

1-Week Range:

$0.2548

$0.409

52-Week Range:

$0.24

$2.51

Fibrobiologics Inc Stock (FBLG) Company Profile

Name

Fibrobiologics Inc

Sector

Healthcare (1123)

Industry

Biotechnology (627)

Phone

281-671-5150

Address

455 E. MEDICAL CENTER BLVD, HOUSTON

Employee

Twitter

Next Earnings Date

Latest SEC Filings

FBLG's Discussions on Twitter

Compare FBLG with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
FBLG Fibrobiologics Inc	0.3929	21.31M	0	-17.78M	-10.52M	-0.5492
VRTX Vertex Pharmaceuticals Inc	452.04	113.14B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	741.29	78.49B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	877.94	54.76B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	397.55	54.51B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	197.01	41.64B	447.02M	-1.18B	-906.14M	-6.1812

Fibrobiologics Inc Stock (FBLG) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-12-24	Initiated	Rodman & Renshaw	Buy
Oct-30-24	Initiated	H.C. Wainwright	Buy
Sep-24-24	Initiated	Maxim Group	Buy

Fibrobiologics Inc Stock (FBLG) Latest News

Dec 12, 2025

Major Stock Acquisition: Insider Buys Big in FibroBiologics! - TipRanks

Dec 12, 2025

Garcia, FibroBiologics general counsel, buys $47,600 in stock By Investing.com - Investing.com Australia

Dec 12, 2025

Garcia, FibroBiologics general counsel, buys $47,600 in stock - Investing.com

Dec 12, 2025

FibroBiologics (NASDAQ:FBLG) Trading 4.8% Higher – What’s Next? - Defense World

Dec 12, 2025

Dec 10, 2025

Why Is FibroBiologics Stock Trading Higher Today?FibroBiologics (NASDAQ:FBLG) - Benzinga

Dec 10, 2025

FibroBiologics submits new patent application with USPTO - TipRanks

Dec 10, 2025

FibroBiologics files patent for fibroblast therapy in joint repair - Investing.com

Dec 10, 2025

FibroBiologics Submits New Patent Application for Fibroblast-Derived Therapy in Orthopedic and Musculoskeletal Conditions - Quiver Quantitative

Dec 10, 2025

FibroBiologics Files Patent Application Covering Novel Fibroblast-Based Chondrocyte Spheroid Platform for Orthopedic and Musculoskeletal Conditions - marketscreener.com

Dec 10, 2025

Dec 08, 2025

Does FibroBiologics Inc (FBLG) offer a good opportunity for investors? - Setenews

Dec 08, 2025

Dec 06, 2025

FibroBiologics announces payoff of outstanding debt - MSN

Dec 06, 2025

Dec 04, 2025

Will FibroBiologics Inc. (SG0) stock deliver stable dividendsRisk Management & Expert Approved Momentum Trade Ideas - Newser

Dec 04, 2025

Dec 02, 2025

FibroBiologics prices 4.48M shares at 33.5c in registered direct offering - MSN

Dec 02, 2025

Is FibroBiologics Inc. (SG0) stock good for long term investingQuarterly Growth Report & Technical Pattern Recognition Alerts - Newser

Dec 02, 2025

Is FibroBiologics Inc. stock dividend yield sustainableWeekly Trade Summary & Verified Momentum Watchlists - Newser

Dec 02, 2025

Is FibroBiologics Inc. (SG0) stock included in top ETFsIPO Watch & Risk Managed Investment Strategies - Newser

Dec 02, 2025

Dec 01, 2025

Prepare Yourself for Liftoff: FibroBiologics Inc (FBLG) - setenews.com

Dec 01, 2025

Nov 30, 2025

Reviewing FibroBiologics (NASDAQ:FBLG) and Axsome Therapeutics (NASDAQ:AXSM) - Defense World

Nov 30, 2025

Nov 28, 2025

Will FibroBiologics Inc. stock gain from strong economyJuly 2025 Closing Moves & Technical Buy Zone Confirmations - BỘ NỘI VỤ

Nov 28, 2025

Nov 26, 2025

FibroBiologics repays convertible notes, eliminating dilution risk By Investing.com - Investing.com Nigeria

Nov 26, 2025

FibroBiologics repays convertible notes, eliminating dilution risk - Investing.com India

Nov 26, 2025

FibroBiologics Announces Payoff of Outstanding Debt - The Manila Times

Nov 26, 2025

FibroBiologics (Nasdaq: FBLG) retires $15M Yorkville notes, keeps access to $25M SEPA - Stock Titan

Nov 26, 2025

Nov 25, 2025

FibroBiologics closes $1.5 million registered direct offering By Investing.com - Investing.com Nigeria

Nov 25, 2025

Fibrobiologics announces closing of $1.5 million registered direct offering priced at-the-market under Nasdaq rules - marketscreener.com

Nov 25, 2025

Fibrobiologics Announces Closing Of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - TradingView

Nov 25, 2025

FibroBiologics Closes $1.5 Million Registered Direct Share Offering - marketscreener.com

Nov 25, 2025

FibroBiologics closes $1.5 million registered direct offering - Investing.com

Nov 25, 2025

FibroBiologics Announces Closing of $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewswire

Nov 25, 2025